Following various incidents in recent years, the control mechanisms for medical devices are being tightened throughout Europe with the new EU Medical Device Regulation (MDR) and In Vitro Diagnostics Regulation (IVDR). What is the impact of these EU regulations for Switzerland and how do you ensure compliance on your end by the time the transition period ends?
The success of the EU’s Digital Single Market requires secure cross-border electronic transactions. Reliable electronic identification (eID) and trust services such as the creation and verification of electronic signatures are essential. eIDAS Regulation ensures seamless eID and trust across the EU.
The Automatic Exchange of Information (AEoI) has been in force in Switzerland since 1 January 2017. This means that Switzerland will start exchanging 2017 data with the EU member states, Australia, Guernsey, Isle of Man, Iceland, Japan, Jersey, Canada, Norway and South Korea for the first time in September 2018. But what does this really mean?